Treximet
Product Images NDC 21695-954

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Treximet (NDC 21695-954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sumatriptan Chemical Structure (E08d5f22 F9c3 4627 8e5a 72c95183cf6a 01)

Chemical structure of the active ingredient depicted in the image, showing a complex molecule with an indole-like structure and various functional groups, including carboxylic acid and amine groups, consistent with the drug TREXIMET.*

FDA Label Image

Naproxen Chemical Structure (E08d5f22 F9c3 4627 8e5a 72c95183cf6a 02)

Chemical structure diagram of the active ingredient shown on the label of TREXIMET. The structure includes benzene rings and a carboxylate (COONa) group, suggesting a complex aromatic compound relevant to the medication.*

FDA Label Image

Figure 1. Percentage Of Patients With Initial Headache Pain Relief Within 2 Hours (E08d5f22 F9c3 4627 8e5a 72c95183cf6a 03)

A line graph comparing the percentage of patients with relief over time up to 2 hours postdose for four groups: TREXIMET, Sumatriptan 85 mg, Naproxen Sodium 500 mg, and Placebo. The y-axis shows the percentage of patients with relief, and the x-axis shows hours postdose from 0 to 2 hours.*

FDA Label Image

Figure 2. Cumulative Percentage Of Subjects Taking A Rescue Medication Over The 24 Hours Following The First Dosea (E08d5f22 F9c3 4627 8e5a 72c95183cf6a 04)

A line graph comparing the cumulative percentage of subjects rescued over 24 hours among four groups: Placebo, Naproxen Sodium, Sumatriptan, and TREXIMET. The x-axis represents time to rescue in hours, and the y-axis represents the cumulative percentage of subjects who were rescued. The Placebo group shows the highest cumulative rescue rate, followed by Naproxen Sodium, Sumatriptan, and TREXIMET with the lowest.*

FDA Label Image

Treximet 85mg/500mg (E08d5f22 F9c3 4627 8e5a 72c95183cf6a 05)

TREXIMET 85mg/500mg tablets label featuring the Physician Partner branding. It states each tablet contains 85mg of Sumatriptan and 500mg of Naproxen Sodium. The label includes NDC 21695-954-09, manufacturer GlaxoSmithKline Research, and storage instructions to keep the medication at controlled room temperature (15°-30°C). Distributed by Physician Partner, Thousand Oaks, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.